BRAF and melanoma: In mice implanted with BRAF-mutant melanoma cells, a different combinatorial method utilizing fisetin and sorafenib (an RAF inhibitor) has recently shown suppression of melanoma cell proliferation, induction of apoptosis, and prevention of tumor growth.